XM does not provide services to residents of the United States of America.

Capgemini cuts revenue forecast again as soft markets hit Q3 sales



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Capgemini cuts revenue forecast again as soft markets hit Q3 sales</title></head><body>

Adds shares in paragraph 4, analyst comments in paragraphs 5-6

By Leo Marchandon

Oct 30 (Reuters) -French IT consulting group Capgemini CAPP.PA cut its 2024 revenue forecast for the second time this year on Wednesday, after continued weakness in some of its markets, especially manufacturing, hit third-quarter sales.

The company, which offers services ranging from cloud and AI to enterprise management across a wide array of industries, had in July forecast a surprise fall in its annual revenue due to a downturn in the automotive and aerospace sectors.

The Paris-based group now expects its revenue to decline between 2% and 2.4% at a constant currency basis, versus its previous forecast for a drop of 0.5% to 1.5%.

Its shares fell 6.6% by 0902 GMT, among the worst performers of Europe's benchmark STOXX 600 index .STOXX.

"The group lacks momentum in 2024 and potentially in 2025," said Sarah Thirion, analyst at Midcap Partners, pointing to the discretionary nature of spending and Capgemini's exposure to the automotive sector and weak European markets.

However, she added "the prospect of a gradual improvement in profitability remains intact beyond 2025".

Capgemini's third-quarter revenue fell 1.6% at constant exchange rates to 5.38 billion euros ($5.82 billion).

"In a market that remains soft overall, we expect to deliver a similar growth in Q4," CEO Aiman Ezzat said in the statement, though he added the company expected headwinds in tech and telecom sectors to ease gradually.

"Client demand continues to be driven by operational efficiencies and cost reduction and we seize their growing appetite for AI and Gen AI services," Ezzat said.

($1 = 0.9244 euros)



Reporting by Leo Marchandon in Gdansk; editing by Milla Nissi

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.